Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
February 2016

Drugs for Dementia
Current medications for dementia do little to improve cognition or function.

Two New Long-Acting IM Antipsychotics
Aripiprazole lauroxil (Aristada) and a 3-month formulation of paliperidone palmitate (Invega Trinza) have been approved for the treatment of schizophrenia.

Exercise for Late-Life MDD
In a study of older patients with major depressive disorder, both high- and low-intensity exercise added to antidepressant treatment improved remission rates and time to remission.

In Brief
Offspring of Mothers with Polycystic Ovary Syndrome Have Increased Risk of Autism; Androgen Deprivation Therapy Linked to Increased Risk of Alzheimer Disease

A Drug Combination for Agitation in Dementia
In a multicenter trial, the combination of dextromethorphan and quinidine sulfate (Nuedexta) was statistically superior to placebo as a treatment for agitation in patients with Alzheimer disease.

Affiliated Links

The Journal of Clinical Psychiatry

The University of Arizona Health Sciences Center- Department of Psychiatry

American Academy of Child and Adolescent Psychiatry

American Association of Suicidology

American Psychiatric Association

American Society for Adolescent Psychiatry

American Society of Addiction Medicine

American Society of Clinical Psychopharmacology

Autism Society of America

Depression and Bipolar Support Alliance (DBSA)

National Alliance for Research on Schizophrenia and Depression (NARSAD)

National Alliance for the Mentally Ill

National Association of Alcoholism and Drug Abuse Counselors

National Institute of Mental Health

National Mental Health Association